“Rethinking regulatory for speed and efficiency”

Cory Wohlbach, Global Vice President Biosimilar Regulatory Affairs at Teva and Co-chair of the Biosimilar Forum. Recently spoke on behalf of the Association for Accessible Medicine’s Biosimilars Council about BsUFA III.